US Patent 10246709 Targeting ligands for therapeutic compounds
Patent 10246709 was granted and assigned to Arrowhead Pharmaceuticals, Inc. on April, 2019 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10246709 Targeting ligands for therapeutic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.